Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 | NEJM
Original Article from The New England Journal of Medicine — Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
Original Article from The New England Journal of Medicine — Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
Two studies presented at ASCO23 demonstrate the critical importance of access to comprehensive genomic profiling in patients with NSCLC and mCRC (Abstracts 3602 and 6506).
Afami-cel treatment resulted in durable responses in heavily pre-treated patients with HLA-A*02 and MAGE-A4-expressing synovial sarcoma. This study shows that T-cell receptor therapy can be…
Nature Reviews Drug Discovery – Discover the world’s best science and medicine | Nature.com
Nature Reviews Genetics – This Review surveys the known mechanisms of communication between RBPs and their effectors and their roles in reducing the complexity of…
Review Article from The New England Journal of Medicine — Key Issues as Wearable Digital Health Technologies Enter Clinical Care
Review Article from The New England Journal of Medicine — Key Issues as Wearable Digital Health Technologies Enter Clinical Care
Development of medicines in rare oncologic patient populations are growing, but well-powered randomized controlled trials are typically extremely challenging or unethical to conduct in such…
Novel tissue-agnostic therapeutics targeting driver mutations in tumor cells have been recently approved by FDA, driven by basket trials that have demonstrated their efficacy and…
VivekSubbiah & colleagues delve into the @ASCO #TAPURStudy, shedding light on the importance of targeting ALL #BRAFAlterations, beyond V600E. (Re)-search continues, urging us to push…